Example of costing of Clinical Trial Budget

1:1
Budget example showing low and high cost ranges for a Phase 1 rare disease clinical trial with twenty subjects.

Budget example providing low and high cost estimates for a Phase 1 clinical trial with 20 subjects, broken down by workstreams including study design and protocol, regulatory affairs, project management, investigator sites, patient recruitment and retention, genomics component, clinical data management, monitoring and pharmacovigilance, investigational medicinal product costs, statistics and publication, and institutional overheads. It includes subtotal and total ranges and a cost-per-patient estimate.

blank

publication

Year of publication

2026

Source

European Rare Diseases Research Alliance (ERDERA)

Author

You might also be interested in

The European Rare Diseases Research Alliance (ERDERA), together with the European Reference Networks (ERNs), provides the missing operational layer required to implement the European Biotech Act across the full innovation pathway —from discovery to patient access.
ERDERA will launch its Clinical Trial Call 2026 (ECTC) on 1 July 2026, supporting multinational, GCP‑compliant early‑phase interventional clinical trials in rare diseases.
Pre-announcement describing scope, eligibility and indicative timeline for the ERDERA Clinical Trial Call 2026, expected to open on 1 July 2026.